Adial Pharmaceuticals, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adial Pharmaceuticals, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $140.33K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $609.61K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $513.69K, a 59.66% decline from fiscal 2022.
- Adial Pharmaceuticals, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.27M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $513.69K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $140.33K 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $609.61K 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $1.27M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |